🔗 Visit the ClinicalTrials.gov page for NCT01943682
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment. | South Asian J Cancer | 2015 | 0.77 |
| 2 | A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program. | Leukemia | 2016 | 0.76 |